Genefitletics

The innovation in healthcare is still on the backseat with focus on existing primitive biomarkers which the healthcare practitioners have been tracking for decades.We still rely on routine blood biomarkers be it HDL, LDL, Hba1c, Homocysteine & more that just tells a macro level view & does not provide insights that could drive health promoting outcomes.Now we have seen a number of healthtech startups adding a wearable layer to these routine blood works & assume that marriage of these two( irrelevant) measures will help address health to the core?What are these companies even thinking ?If we go down & understand human evolution which dates back to 1.5 billion years ago, multicellularity defines how our cells operate collectively towards larger morphogenetic objectives & are bound by a social contract. In fact, it is ancient bacteria- mitochondria that controls this cell collective & drives cell to cell communication, behavior & decision making via transmitting signals using the bioelectric network of the cell collective.These mitochondria via its information processing system can process & integrate information & release biochemical signals that tell nucleus to turn on or off specific genes that codes for specific proteins that triggers cell to cell communication. This communication may tell the immune cell to grab all energy to address the toxin insults, make or disrupt hormone production, raise blood sugar, blood pressure & more.This clearly reflects that the focus should be understanding the interaction between environment, microbiome & mitochondria, reprogramming the bioelectric signalling that could drive big anatomical results to reinstate cellular homeostasis.Our founders Sushant & Sakshi deep dive into discussing why focussing on blood works + wearables is irrelevant & cannot help you transform your biology. Know how Genefitletics is making an impact in helping you achieve the best of your health www.genefitletics.com/orahyg